ConductScience.org, home

Paper39675926

Demographic and Treatment Analysis of Periosteal Osteosarcoma.

Larkins MC. Cancer Rep (Hoboken), 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Demographic and Treatment Analysis of Periosteal Osteosarcoma. Papers, record 39675926. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39675926

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Demographic and Treatment Analysis of Periosteal Osteosarcoma.
PubMed
Journal
Cancer Rep (Hoboken)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.12, provisional
iCite
Revised in PubMed
2026-07-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Larkins MCMichael Chttps://orcid.org/0000-0002-2322-8345

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OsteosarcomaMajor topic
Bone NeoplasmsMajor topic
SEER ProgramMajor topic
PeriosteumMajor topic
Humans
Female
Male
Young Adult
Adult
Adolescent
Middle Aged
United States
Child
Retrospective Studies

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119418830NCI SEER public-use data: applications and limitations in oncology research.Oncology (Williston Park)2009https://conductscience.org/library/papers/19418830PubMed
232506177The effect of preoperative radiotherapy on local control and prognosis in high-grade non-metastatic intramedullary osteosarcoma of the extremities.Arch Orthop Trauma Surg2021https://conductscience.org/library/papers/32506177PubMed
334567961Chemotherapy in the management of periosteal osteosarcoma: A narrative review.J Bone Oncol2021https://conductscience.org/library/papers/34567961PubMed
419197972Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.Cancer2009https://conductscience.org/library/papers/19197972PubMed
538545575Prognostic Factors Influencing Survival and Oncological Outcome in Patients with Parosteal Osteosarcoma.Indian J Surg Oncol2024https://conductscience.org/library/papers/38545575PubMed
625784972Periosteal osteosarcoma: a review of clinical evidence.Int J Clin Exp Med2015https://conductscience.org/library/papers/25784972PubMed
73472700Periosteal osteosarcoma.Clin Orthop Relat Res1987https://conductscience.org/library/papers/3472700PubMed
815852358Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.Cancer2005https://conductscience.org/library/papers/15852358PubMed
916290134Periosteal osteosarcoma--a European review of outcome.Eur J Cancer2005https://conductscience.org/library/papers/16290134PubMed
1021272969Periosteal osteosarcoma of the mandible: case report and review of the literature.J Oral Maxillofac Surg2011https://conductscience.org/library/papers/21272969PubMed
116586725Parosteal osteosarcoma.J Bone Joint Surg Br1984https://conductscience.org/library/papers/6586725PubMed
1237899480How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology.Mil Med Res2023https://conductscience.org/library/papers/37899480PubMed
1321472720Periosteal osteosarcoma: a single-institution experience.Cancer2011https://conductscience.org/library/papers/21472720PubMed
1435192571Characteristics, Management, and Outcomes of Patients With Osteosarcoma: An Analysis of Outcomes From the National Cancer Database.J Am Acad Orthop Surg Glob Res Rev2022https://conductscience.org/library/papers/35192571PubMed
1535878549Periosteal osteosarcoma of the clavicle: A case report and review of the literature.Int J Surg Case Rep2022https://conductscience.org/library/papers/35878549PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41341865Intelligent Nanomedicine Systems Utilizing Diverse Nanoparticles for Osteosarcoma Therapy: A Review.Int J Nanomedicine2025https://conductscience.org/library/papers/41341865

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39675926

GET https://conductscience.org/api/papers/v1/39675926/authors